Chandan Healthcare's Q1 FY 2026-27 Quarterly Results

Result Summary

• Chandan Healthcare Ltd reported a 6.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 19.7%.
• Its expenses for the quarter were up by 4.7% QoQ and 22.5% YoY.
• The net profit increased 7.0% QoQ and decreased 13.9% YoY.
• The earnings per share (EPS) of Chandan Healthcare Ltd stood at 2.59 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Chandan Healthcare Ltd operates within the healthcare industry, focusing primarily on providing medical products and services. The company is involved in the manufacturing and distribution of pharmaceutical products, medical devices, and healthcare solutions aimed at enhancing patient care and treatment outcomes. As of the current analysis, there is no specific information available regarding recent major developments within the company. However, Chandan Healthcare Ltd is known for its commitment to quality and innovation in healthcare, striving to meet the diverse needs of patients and healthcare providers.

Revenue

For the quarter ending Q1FY27, Chandan Healthcare Ltd reported a total income of ₹82.26 crores. This represents a quarter-over-quarter (QoQ) increase of 6.3% compared to the preceding quarter, Q4FY26, which recorded a total income of ₹77.41 crores. Additionally, there is a year-over-year (YoY) growth of 19.7% when compared to the same quarter in the previous year, Q1FY26, which had a total income of ₹68.75 crores. This growth in revenue reflects an upward trend in the company’s income over both the quarter and year periods.

Profitability

Chandan Healthcare Ltd's profitability metrics for Q1FY27 indicate a profit before tax of ₹11.69 crores. This shows a significant QoQ increase of 25.4% from ₹9.32 crores in Q4FY26 and a YoY increase of 5.0% from ₹11.13 crores in Q1FY26. The company's tax expense for Q1FY27 is ₹3.77 crores, which increased by 63.9% QoQ and 31.4% YoY. Consequently, the profit after tax for Q1FY27 is ₹7.50 crores, showing a 7.0% increase QoQ but a decline of 13.9% YoY compared to Q1FY26's ₹8.71 crores. Earnings per share for Q1FY27 are recorded at ₹2.59, marking a 2.4% increase from the previous quarter, Q4FY26.

Operating Metrics

In examining the company's operating metrics, total expenses for Q1FY27 amounted to ₹70.58 crores. This is a 4.7% increase from Q4FY26's total expenses of ₹67.40 crores and a 22.5% increase from Q1FY26's ₹57.61 crores. These figures indicate a consistent rise in the company's operating costs over the periods analyzed. The data reflects an overall increase in expenses, which is aligned with the rise in total income, suggesting growth in the scale of operations. No additional operational metrics or ratios are available from the provided data to further analyze operational efficiency or cost management strategies.